SCHEMBL30147545

SCHEMBL30147545

CNC(=O)c1cccc(C(F)F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
SLC7A5 Q01650 1/20 0.48
ROCK2 O75116 2/20 0.47
PRMT5 O14744 1/20 0.46
KMT2A Q03164 3/20 0.46
HSD17B10 Q99714 2/20 0.46
GAA P10253 1/20 0.46
ALDH1A1 P00352 2/20 0.45
KAT6A Q92794 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PTGS1 P23219 3/20 0.44
PTGS2 P35354 3/20 0.44
MAPT P10636 2/20 0.44
CXCR1 P25024 2/20 0.44
CXCR2 P25025 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RECQL P46063 1/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276759 0.87 HDAC8 (0.59) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL2426452 0.86 HDAC8 (0.58) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL12052142 0.84 HDAC8 (0.56) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL22924510 0.84 NPSR1 (0.62) ROCK2GAAALDH1A1NPSR1LMNA
SCHEMBL19967450 0.84 HDAC8 (0.56) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL8250624 0.84 HDAC8 (0.56) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL8251251 0.84 HDAC8 (0.56) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL19961183 0.83 HDAC8 (0.54) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL14108019 0.81 HDAC8 (0.53) HDAC8HDAC6SLC7A5ROCK2KMT2A
SCHEMBL28360437 0.81 LMNA (0.51) KMT2AALDH1A1KAT6ANPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF NSD3, PML, NSD1 HDAC8 16/4885HDAC6 161/4885SLC7A5 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.